Jared Coffman, MD
Interventional Pain Medicine · Fort Wayne, INNPI 1053579151
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Boston Scientific at 49.2% of the total. Reporting peaked in 2023 at $2,916 and has fallen 85.8% since, to $414 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in IN, where the typical reported total is $4,157.
Across 58 payments — averaging $77.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Choice Spine, LLC$497
- Stimwave Technologies Incorporated$389
- Spinal Simplicity, LLC$296
- Collegium Pharmaceutical, Inc.$279
- Nalu Medical, Inc.$278
- plus $540 from 12 others
What the payments were for
- Travel & lodging$2,24650%
- Food & beverage$2,24050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $2,206 |
| Choice Spine, LLC | 1 | $497 |
| Stimwave Technologies Incorporated | 4 | $389 |
| Spinal Simplicity, LLC | 2 | $296 |
| Collegium Pharmaceutical, Inc. | 16 | $279 |
| Nalu Medical, Inc. | 3 | $278 |
| Pfizer | 13 | $149 |
| Curonix LLC | 1 | $147 |
| Lilly USA, LLC | 3 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| AbbVie | 1 | $28 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Antares Pharma, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Halozyme Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Blackhawk Cervical Spacer System$497
- Boomerang$497
- TIGERSHARK C$497
- Harrier SA Lumbar Interbody System$497
- Stratofuse$497
- StimQ Receiver Stimulator Kit Channel A US w Receiver$298
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$298
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$298
- Freedom 4A Receiver Kit Channel A US w Receiver$298
- Freedom 8A Receiver Kit Channel A US w Receiver$298
- HA MINUTEMAN G3-R$208
- Nalu Neurostimulation System$149
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$147
- ARTISAN$118
How this compares
$4,486 in reported general payments places this provider in the 50th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 30 | $24,743 |
| OxycontinOxycodone Hcl | 18 | $13,447 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 322 | $12,983 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 309 | $8,741 |
| LinzessLinaclotide | 12 | $6,529 |
| Buprenorphine | 37 | $6,045 |
| Pregabalin | 157 | $4,963 |
| Oxycodone Hcl | 131 | $4,854 |
| Naloxone Hcl | 75 | $4,165 |
| Gabapentin | 351 | $3,913 |
| Tizanidine Hcl | 138 | $2,124 |
| Fentanyl | 20 | $2,103 |
| Amitriptyline Hcl | 171 | $1,900 |
| Morphine Sulfate ErMorphine Sulfate | 51 | $1,216 |
| Cyclobenzaprine Hcl | 107 | $1,172 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $279 | $24,74330 claims |
| AbbVieLinzess | $28 | $6,52912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 68 interventional pain medicine providers in Indiana.
Other interventional pain medicine in Fort Wayne
- George BojrabFort Wayne$7K
- Joshua WellingtonCarmel$315K
- Joseph RutledgeLafayette$96K
- Orlando LandrumElkhart$34K
- Mahendra SanapatiEvansville$31K
- Nikhil ShettyMunster$29K
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
- Jocelyn BushIndianapolis$20K
- Scott KimGreenwood$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.